

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 7.06158627 |
| 2 | B cell mediated immunity (GO:0019724) | 5.54171372 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.21988162 |
| 4 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.02079224 |
| 5 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 4.78570722 |
| 6 | regulation of antigen processing and presentation (GO:0002577) | 4.71912419 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.71412539 |
| 8 | positive thymic T cell selection (GO:0045059) | 4.60423244 |
| 9 | positive regulation of antigen processing and presentation (GO:0002579) | 4.59174269 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.56077183 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.43196741 |
| 12 | detection of bacterium (GO:0016045) | 4.41789935 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.36600236 |
| 14 | detection of other organism (GO:0098543) | 4.29178293 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.24582744 |
| 16 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.21468864 |
| 17 | T-helper 1 type immune response (GO:0042088) | 4.06569421 |
| 18 | type I interferon signaling pathway (GO:0060337) | 4.03363871 |
| 19 | cellular response to type I interferon (GO:0071357) | 4.03363871 |
| 20 | response to type I interferon (GO:0034340) | 4.00948359 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.94536362 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.94536362 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 3.91126034 |
| 24 | response to peptidoglycan (GO:0032494) | 3.85432033 |
| 25 | * cellular response to interferon-gamma (GO:0071346) | 3.83896544 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 3.79402365 |
| 27 | * response to interferon-gamma (GO:0034341) | 3.53435467 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.53222458 |
| 29 | positive regulation of type 2 immune response (GO:0002830) | 3.50112620 |
| 30 | response to interferon-beta (GO:0035456) | 3.47343071 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45763171 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.44629634 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 3.44629634 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.44629634 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.44629634 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.44629634 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.44629634 |
| 38 | positive T cell selection (GO:0043368) | 3.42887481 |
| 39 | eosinophil chemotaxis (GO:0048245) | 3.42384562 |
| 40 | production of molecular mediator of immune response (GO:0002440) | 3.40927039 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39440818 |
| 42 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.36383689 |
| 43 | * T cell costimulation (GO:0031295) | 3.35651456 |
| 44 | * lymphocyte costimulation (GO:0031294) | 3.30409173 |
| 45 | positive regulation of B cell differentiation (GO:0045579) | 3.28645059 |
| 46 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.25011746 |
| 47 | eosinophil migration (GO:0072677) | 3.22445065 |
| 48 | defense response to protozoan (GO:0042832) | 3.19553668 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.18133275 |
| 50 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.17218280 |
| 51 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.15451732 |
| 52 | granulocyte activation (GO:0036230) | 3.15419288 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14225510 |
| 54 | B cell receptor signaling pathway (GO:0050853) | 3.14063997 |
| 55 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.12586931 |
| 56 | germinal center formation (GO:0002467) | 3.09635408 |
| 57 | myeloid dendritic cell activation (GO:0001773) | 3.09027022 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.08451673 |
| 59 | regulation of interferon-alpha production (GO:0032647) | 3.06905551 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.06528686 |
| 61 | neutrophil activation (GO:0042119) | 3.04391775 |
| 62 | regulation of T cell tolerance induction (GO:0002664) | 3.03115769 |
| 63 | response to protozoan (GO:0001562) | 2.97605562 |
| 64 | negative regulation of viral genome replication (GO:0045071) | 2.94266333 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 2.93399636 |
| 66 | positive regulation of interferon-alpha production (GO:0032727) | 2.93224024 |
| 67 | T cell migration (GO:0072678) | 2.92847223 |
| 68 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.92291557 |
| 69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89213282 |
| 70 | regulation of mononuclear cell migration (GO:0071675) | 2.86188461 |
| 71 | regulation of tolerance induction (GO:0002643) | 2.82916918 |
| 72 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.81849379 |
| 73 | regulation of macrophage chemotaxis (GO:0010758) | 2.80539713 |
| 74 | T cell selection (GO:0045058) | 2.78625838 |
| 75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77019817 |
| 76 | response to host immune response (GO:0052572) | 2.77019817 |
| 77 | lymphocyte mediated immunity (GO:0002449) | 2.76677390 |
| 78 | regulation of mast cell activation (GO:0033003) | 2.76553238 |
| 79 | positive regulation of lymphocyte migration (GO:2000403) | 2.76540993 |
| 80 | lymphocyte chemotaxis (GO:0048247) | 2.76206694 |
| 81 | thymic T cell selection (GO:0045061) | 2.75741755 |
| 82 | adaptive immune response (GO:0002250) | 2.74836911 |
| 83 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.74503587 |
| 84 | microglial cell activation (GO:0001774) | 2.74247586 |
| 85 | regulation of mast cell degranulation (GO:0043304) | 2.74036661 |
| 86 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.71582283 |
| 87 | regulation of type 2 immune response (GO:0002828) | 2.71069282 |
| 88 | negative thymic T cell selection (GO:0045060) | 2.70481079 |
| 89 | regulation of lymphocyte migration (GO:2000401) | 2.69942194 |
| 90 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.69642371 |
| 91 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.69620850 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 2.68426220 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66213494 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.64401121 |
| 95 | NIK/NF-kappaB signaling (GO:0038061) | 2.63927483 |
| 96 | regulation of B cell differentiation (GO:0045577) | 2.62794056 |
| 97 | macrophage activation (GO:0042116) | 2.62444621 |
| 98 | cellular response to exogenous dsRNA (GO:0071360) | 2.61683503 |
| 99 | peptide catabolic process (GO:0043171) | 2.60502954 |
| 100 | cytidine catabolic process (GO:0006216) | 2.60089585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.62691515 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.00074046 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.86158873 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.70742152 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.41121857 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.29618936 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.15681302 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03264691 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.90642033 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.81903574 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.64316187 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.61421201 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53372987 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.52079394 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50253341 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.39039892 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.25491452 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22714006 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18607640 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15827917 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.13444896 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08008442 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.91759197 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91388000 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90452666 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88348210 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81121826 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.76532282 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74905479 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.74853851 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.71352092 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70730940 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68100953 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.66766600 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62180455 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60733743 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56438657 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56022493 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53648118 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53555928 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48240382 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46247866 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46175017 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45048494 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43234306 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33608665 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31666974 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.30128197 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29989241 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.27624658 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27345342 |
| 52 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.22758059 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22339251 |
| 54 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20910697 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19598978 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.18906852 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16734499 |
| 58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15175382 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14951005 |
| 60 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13468590 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10821566 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09500877 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09038551 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08533572 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07569913 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06739631 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06593640 |
| 68 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06189819 |
| 69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05227971 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05094215 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02440461 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01817068 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01786170 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00301155 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98716023 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96808416 |
| 77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.96223546 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96164076 |
| 79 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.93782092 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92988088 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91850682 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91585307 |
| 83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90797602 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90615041 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89912304 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89718879 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89261583 |
| 88 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88986522 |
| 89 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86840780 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86505362 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83168341 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81797078 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80861740 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 0.79430384 |
| 95 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76536200 |
| 96 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.73803711 |
| 97 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.73009498 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72957132 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72693066 |
| 100 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.71959670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.43567457 |
| 2 | MP0005671_abnormal_response_to | 3.59986083 |
| 3 | MP0003724_increased_susceptibility_to | 3.54067007 |
| 4 | MP0003436_decreased_susceptibility_to | 3.43230918 |
| 5 | MP0003303_peritoneal_inflammation | 3.34626447 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.28474008 |
| 7 | MP0009785_altered_susceptibility_to | 3.24710761 |
| 8 | MP0001790_abnormal_immune_system | 3.03388482 |
| 9 | MP0005387_immune_system_phenotype | 3.03388482 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.99393260 |
| 11 | MP0006082_CNS_inflammation | 2.92772733 |
| 12 | MP0001800_abnormal_humoral_immune | 2.89776253 |
| 13 | MP0005025_abnormal_response_to | 2.80442211 |
| 14 | MP0002419_abnormal_innate_immunity | 2.71327607 |
| 15 | MP0000685_abnormal_immune_system | 2.65706904 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.56988901 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.55672651 |
| 18 | MP0002723_abnormal_immune_serum | 2.54635227 |
| 19 | MP0010155_abnormal_intestine_physiology | 2.33950414 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.29684855 |
| 21 | MP0001819_abnormal_immune_cell | 2.28091438 |
| 22 | MP0009840_abnormal_foam_cell | 2.20573323 |
| 23 | MP0003183_abnormal_peptide_metabolism | 2.00772590 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.97863234 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.97350725 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.96527157 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.94266843 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.94259965 |
| 29 | MP0009764_decreased_sensitivity_to | 1.83672206 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.82903723 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.79508513 |
| 32 | MP0000716_abnormal_immune_system | 1.72999266 |
| 33 | MP0003075_altered_response_to | 1.72902443 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.70950724 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.69647030 |
| 36 | MP0008469_abnormal_protein_level | 1.66880729 |
| 37 | MP0004947_skin_inflammation | 1.57681365 |
| 38 | MP0002398_abnormal_bone_marrow | 1.57516032 |
| 39 | MP0002405_respiratory_system_inflammati | 1.57033583 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.55228665 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.50895655 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.49061558 |
| 43 | MP0000343_altered_response_to | 1.48185264 |
| 44 | MP0003866_abnormal_defecation | 1.45930284 |
| 45 | MP0001853_heart_inflammation | 1.43108796 |
| 46 | MP0005166_decreased_susceptibility_to | 1.40686626 |
| 47 | MP0002429_abnormal_blood_cell | 1.35416495 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.33093335 |
| 49 | MP0000604_amyloidosis | 1.32644123 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.32033607 |
| 51 | MP0005310_abnormal_salivary_gland | 1.28786932 |
| 52 | MP0005360_urolithiasis | 1.22020143 |
| 53 | MP0002722_abnormal_immune_system | 1.20532305 |
| 54 | MP0001873_stomach_inflammation | 1.20523151 |
| 55 | MP0008004_abnormal_stomach_pH | 1.19138299 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.15483548 |
| 57 | MP0009278_abnormal_bone_marrow | 1.13453407 |
| 58 | MP0003448_altered_tumor_morphology | 1.11364853 |
| 59 | MP0000858_altered_metastatic_potential | 1.08556049 |
| 60 | MP0005365_abnormal_bile_salt | 1.07947258 |
| 61 | MP0001663_abnormal_digestive_system | 1.05099688 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.05078466 |
| 63 | MP0005451_abnormal_body_composition | 1.04670757 |
| 64 | MP0002006_tumorigenesis | 1.03906234 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 0.98167710 |
| 66 | MP0001545_abnormal_hematopoietic_system | 0.98167710 |
| 67 | MP0009763_increased_sensitivity_to | 0.96522112 |
| 68 | MP0005165_increased_susceptibility_to | 0.96276120 |
| 69 | MP0003828_pulmonary_edema | 0.95752205 |
| 70 | MP0004510_myositis | 0.94519722 |
| 71 | MP0003690_abnormal_glial_cell | 0.87602908 |
| 72 | MP0000249_abnormal_blood_vessel | 0.87396227 |
| 73 | MP0002933_joint_inflammation | 0.84583557 |
| 74 | MP0005390_skeleton_phenotype | 0.81852817 |
| 75 | MP0000490_abnormal_crypts_of | 0.80411584 |
| 76 | MP0006054_spinal_hemorrhage | 0.79709715 |
| 77 | MP0009643_abnormal_urine_homeostasis | 0.79333890 |
| 78 | MP0004883_abnormal_blood_vessel | 0.78380378 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.78234369 |
| 80 | MP0005164_abnormal_response_to | 0.77058326 |
| 81 | MP0000703_abnormal_thymus_morphology | 0.75376698 |
| 82 | MP0000920_abnormal_myelination | 0.71532921 |
| 83 | MP0005319_abnormal_enzyme/_coenzyme | 0.70920512 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.70909166 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.70452998 |
| 86 | MP0008260_abnormal_autophagy | 0.69705587 |
| 87 | MP0003045_fibrosis | 0.67522119 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.67322573 |
| 89 | MP0005085_abnormal_gallbladder_physiolo | 0.65872309 |
| 90 | MP0003795_abnormal_bone_structure | 0.64921880 |
| 91 | MP0001666_abnormal_nutrient_absorption | 0.64354381 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64285879 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.63144058 |
| 94 | MP0001501_abnormal_sleep_pattern | 0.62652313 |
| 95 | MP0000609_abnormal_liver_physiology | 0.61958863 |
| 96 | MP0001851_eye_inflammation | 0.61422122 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.58774253 |
| 98 | MP0004019_abnormal_vitamin_homeostasis | 0.56766432 |
| 99 | MP0005535_abnormal_body_temperature | 0.54480426 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.54383269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.36794002 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.46170675 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.44722486 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.37146001 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.37146001 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.37146001 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.28435273 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.17560900 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.97057275 |
| 10 | Meningitis (HP:0001287) | 3.94041689 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93688900 |
| 12 | Myositis (HP:0100614) | 3.92264579 |
| 13 | Pulmonary infiltrates (HP:0002113) | 3.71521442 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.69973232 |
| 15 | Orchitis (HP:0100796) | 3.68219574 |
| 16 | Vasculitis (HP:0002633) | 3.57291017 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.51645798 |
| 18 | Obstructive lung disease (HP:0006536) | 3.51645798 |
| 19 | Optic neuritis (HP:0100653) | 3.49051173 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.49051173 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44711817 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44711817 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.42957441 |
| 24 | Abnormality of the prostate (HP:0008775) | 3.38228781 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.36801354 |
| 26 | Recurrent skin infections (HP:0001581) | 3.35364684 |
| 27 | Glomerulonephritis (HP:0000099) | 3.33973753 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.29448774 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.23891069 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.20775464 |
| 31 | Encephalitis (HP:0002383) | 3.19157337 |
| 32 | Stomatitis (HP:0010280) | 3.15800012 |
| 33 | Hemoptysis (HP:0002105) | 3.15087951 |
| 34 | Dysostosis multiplex (HP:0000943) | 3.12854122 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 3.11274758 |
| 36 | Urticaria (HP:0001025) | 3.10643887 |
| 37 | Recurrent viral infections (HP:0004429) | 3.05700718 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.02513785 |
| 39 | Chronic diarrhea (HP:0002028) | 2.91678843 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.86013769 |
| 41 | Loss of speech (HP:0002371) | 2.81801807 |
| 42 | Chest pain (HP:0100749) | 2.81330517 |
| 43 | Pustule (HP:0200039) | 2.79796220 |
| 44 | Colitis (HP:0002583) | 2.78697942 |
| 45 | Abnormality of the pleura (HP:0002103) | 2.75060836 |
| 46 | Complement deficiency (HP:0004431) | 2.74468530 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 2.69720969 |
| 48 | Disinhibition (HP:0000734) | 2.66920659 |
| 49 | Increased IgM level (HP:0003496) | 2.66050565 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.64432998 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.60739353 |
| 52 | Petechiae (HP:0000967) | 2.60673930 |
| 53 | Recurrent bronchitis (HP:0002837) | 2.60173186 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.59624896 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.54295411 |
| 56 | T lymphocytopenia (HP:0005403) | 2.53721650 |
| 57 | Abnormality of T cells (HP:0002843) | 2.52173128 |
| 58 | Gangrene (HP:0100758) | 2.49879297 |
| 59 | Pulmonary fibrosis (HP:0002206) | 2.49088481 |
| 60 | Pulmonary embolism (HP:0002204) | 2.45616136 |
| 61 | Restrictive lung disease (HP:0002091) | 2.43306024 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.42419311 |
| 63 | Abnormality of complement system (HP:0005339) | 2.42380492 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.42088357 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.41998693 |
| 66 | Gingivitis (HP:0000230) | 2.40126596 |
| 67 | Malnutrition (HP:0004395) | 2.38627275 |
| 68 | Increased serum ferritin (HP:0003281) | 2.37608538 |
| 69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35762400 |
| 70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35762400 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35762400 |
| 72 | Autoimmune hemolytic anemia (HP:0001890) | 2.33838503 |
| 73 | Cellulitis (HP:0100658) | 2.32708047 |
| 74 | Keratoconjunctivitis (HP:0001096) | 2.31926983 |
| 75 | Hypergammaglobulinemia (HP:0010702) | 2.30253070 |
| 76 | Purpura (HP:0000979) | 2.30144657 |
| 77 | Amyloidosis (HP:0011034) | 2.29709052 |
| 78 | Mutism (HP:0002300) | 2.29254604 |
| 79 | Increased IgE level (HP:0003212) | 2.26808057 |
| 80 | Skin rash (HP:0000988) | 2.26172543 |
| 81 | Chronic otitis media (HP:0000389) | 2.26042694 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.20541988 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20541988 |
| 84 | Xerostomia (HP:0000217) | 2.20348637 |
| 85 | Polyneuropathy (HP:0001271) | 2.18251794 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 2.15735038 |
| 87 | Prostate neoplasm (HP:0100787) | 2.13226064 |
| 88 | Nephritis (HP:0000123) | 2.12408018 |
| 89 | Recurrent sinusitis (HP:0011108) | 2.12207837 |
| 90 | Osteomyelitis (HP:0002754) | 2.10308270 |
| 91 | Arthralgia (HP:0002829) | 2.07994469 |
| 92 | Arterial thrombosis (HP:0004420) | 2.07916475 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.06712918 |
| 94 | Lymphopenia (HP:0001888) | 2.06480211 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 2.06438807 |
| 96 | Memory impairment (HP:0002354) | 2.05961032 |
| 97 | Epistaxis (HP:0000421) | 2.05813172 |
| 98 | IgM deficiency (HP:0002850) | 2.05749483 |
| 99 | Abnormality of B cell number (HP:0010975) | 2.04668625 |
| 100 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04207605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.26053716 |
| 2 | MAP4K1 | 4.03761406 |
| 3 | BLK | 3.72911945 |
| 4 | ERN1 | 2.99496703 |
| 5 | TYK2 | 2.91280267 |
| 6 | TXK | 2.88965934 |
| 7 | KIT | 2.73731384 |
| 8 | TBK1 | 2.61072934 |
| 9 | MAP3K14 | 2.52048442 |
| 10 | FES | 2.50094890 |
| 11 | IRAK4 | 2.45301425 |
| 12 | BMPR2 | 2.41773032 |
| 13 | SYK | 2.32823716 |
| 14 | CSF1R | 2.26874299 |
| 15 | IKBKE | 2.08679970 |
| 16 | JAK3 | 2.08627755 |
| 17 | CSK | 2.06383006 |
| 18 | ZAP70 | 1.78347826 |
| 19 | IKBKB | 1.77489838 |
| 20 | LYN | 1.74559250 |
| 21 | MATK | 1.73249653 |
| 22 | GRK7 | 1.72278022 |
| 23 | TESK2 | 1.70322004 |
| 24 | BTK | 1.67436708 |
| 25 | JAK1 | 1.61035576 |
| 26 | TAOK3 | 1.57464489 |
| 27 | ITK | 1.43692563 |
| 28 | IRAK3 | 1.38984821 |
| 29 | MAP2K3 | 1.35273184 |
| 30 | LCK | 1.31335109 |
| 31 | TEC | 1.29867428 |
| 32 | HCK | 1.27595104 |
| 33 | TGFBR2 | 1.26832843 |
| 34 | ACVR1B | 1.25382558 |
| 35 | FGR | 1.24331985 |
| 36 | PRPF4B | 1.17460510 |
| 37 | MAP3K11 | 1.16985814 |
| 38 | GRK6 | 1.11792786 |
| 39 | JAK2 | 1.09574388 |
| 40 | TNK2 | 1.09090236 |
| 41 | MAP3K3 | 1.07152391 |
| 42 | NME2 | 1.04550409 |
| 43 | CDC42BPA | 0.97934277 |
| 44 | KDR | 0.94810419 |
| 45 | MAP3K13 | 0.91144259 |
| 46 | TGFBR1 | 0.91129124 |
| 47 | SIK3 | 0.89964045 |
| 48 | ADRBK2 | 0.87662836 |
| 49 | BMPR1B | 0.85550698 |
| 50 | IRAK1 | 0.83535110 |
| 51 | RIPK1 | 0.82395428 |
| 52 | PRKCQ | 0.81747390 |
| 53 | DDR2 | 0.76842574 |
| 54 | TLK1 | 0.76644386 |
| 55 | TAOK2 | 0.76532185 |
| 56 | TAOK1 | 0.74223114 |
| 57 | CHUK | 0.71392703 |
| 58 | PDK1 | 0.67505024 |
| 59 | CAMKK2 | 0.66958466 |
| 60 | MAPK11 | 0.65195532 |
| 61 | MAP3K1 | 0.62042841 |
| 62 | MAP2K6 | 0.60515753 |
| 63 | MAPK7 | 0.59752348 |
| 64 | STK10 | 0.59587122 |
| 65 | BCKDK | 0.59119516 |
| 66 | SMG1 | 0.57500332 |
| 67 | MARK3 | 0.56358489 |
| 68 | ABL1 | 0.54351269 |
| 69 | FGFR4 | 0.53739750 |
| 70 | FYN | 0.52897647 |
| 71 | MAPKAPK3 | 0.51274386 |
| 72 | FGFR3 | 0.51009082 |
| 73 | PRKG2 | 0.50594159 |
| 74 | HIPK2 | 0.50365103 |
| 75 | PDPK1 | 0.49909589 |
| 76 | MAPK12 | 0.48536251 |
| 77 | PIK3CG | 0.48455411 |
| 78 | MAPKAPK2 | 0.46993859 |
| 79 | PRKCD | 0.45090073 |
| 80 | LRRK2 | 0.43259165 |
| 81 | PIM1 | 0.41761140 |
| 82 | IGF1R | 0.39493412 |
| 83 | CDK19 | 0.39134722 |
| 84 | DAPK2 | 0.38273601 |
| 85 | ABL2 | 0.37897874 |
| 86 | IRAK2 | 0.34562676 |
| 87 | EPHA3 | 0.33866795 |
| 88 | MAP3K5 | 0.33784942 |
| 89 | CDK9 | 0.33358714 |
| 90 | EGFR | 0.33180273 |
| 91 | MAP2K2 | 0.32262040 |
| 92 | MST4 | 0.31733891 |
| 93 | EPHB1 | 0.31337514 |
| 94 | GRK1 | 0.29979944 |
| 95 | SIK2 | 0.29688018 |
| 96 | INSR | 0.28388089 |
| 97 | CDK6 | 0.28061161 |
| 98 | CLK1 | 0.27486307 |
| 99 | RPS6KC1 | 0.26459817 |
| 100 | RPS6KL1 | 0.26459817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Asthma_Homo sapiens_hsa05310 | 4.74907580 |
| 2 | * Allograft rejection_Homo sapiens_hsa05330 | 4.61601149 |
| 3 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.31943017 |
| 4 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.27951679 |
| 5 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.88180264 |
| 6 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.76431158 |
| 7 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.51863267 |
| 8 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.98936358 |
| 9 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.94158086 |
| 10 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.70699314 |
| 11 | * Viral myocarditis_Homo sapiens_hsa05416 | 2.45028711 |
| 12 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.43449630 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.91705450 |
| 14 | * Tuberculosis_Homo sapiens_hsa05152 | 1.88413457 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.88072014 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68746490 |
| 17 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68587751 |
| 18 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.58181301 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54968052 |
| 20 | * Influenza A_Homo sapiens_hsa05164 | 1.53720836 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48538718 |
| 22 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.43791539 |
| 23 | * Phagosome_Homo sapiens_hsa04145 | 1.34865560 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.33068178 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31765046 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.26825242 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19353537 |
| 28 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.17235828 |
| 29 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.13671695 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10581927 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.10528837 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05333306 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.02025779 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99252705 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 0.91732863 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91344382 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91102698 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90624354 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89246125 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87352840 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86900089 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86303609 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84660132 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 0.79527568 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74182826 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72201051 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.68510147 |
| 48 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66855711 |
| 49 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59821259 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.55091558 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53489455 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52887378 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51997091 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51791850 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51536278 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.47078870 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46510743 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46280157 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44650787 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44181256 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44041200 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43953416 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.42494275 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41745752 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.38093641 |
| 66 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.38036047 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.35861319 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34726271 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32814322 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.32219398 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.32001246 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.31774136 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30182373 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30025630 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28338354 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25229301 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25009589 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24392893 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22369257 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.20787011 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20258400 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.19167703 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18917634 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18574594 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.17898954 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17293207 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.16314747 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15920197 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15062948 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13725116 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12854602 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.12736117 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.10525747 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.09896225 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08519379 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.06017744 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.05633115 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.04898837 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.04878086 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.03912699 |

